Raymond G. Watts, M.D. 
WattsHugh J. Morgan Endowed Chair for
      Pediatric Hematology/Oncology                                
Professor of Pediatrics
Division Director
Director of Hemophilia Treatment Center
President, CHS Medical Committee

Dr. Watts is a Professor of Pediatrics and Director of the UAB Division of Pediatric Hematology-Oncology. Dr. Watts is a graduate of the Louisiana State University School of Medicine. He completed pediatric residency training at Arkansas Children's Hospital and joined UAB for fellowship training. He has been a UAB faculty member since 1991. He is board certified in Pediatrics and Pediatric Hematology Oncology. Dr. Watts' research emphasis involves natural history studies in pediatric hematology and oncology, clinical outcomes and innovative therapies for post transplant lymphoproliferative disorder, and hemophilia clinical research. He serves as Director of the UAB Pediatric Hemophilia Clinic and serves on the State of Alabama Hemophilia Oversight Committee. Dr. Watts has been recognized for clinical excellence by selection as one of the "Best Doctors in America" from 2001 to the present.

Elizabeth Alva, M.D.

Smita Bhatia, M.D., MPHBhatia-Smita20-160x190
Professor & Vice Chair of Outcomes for Pediatrics
Director of the School of Medicine Institute for Cancer Outcomes and Survivorship
Associate Director for Outcomes Research of the UAB Comprehensive Cancer Center
Associate Director of the Center for Outcomes and Effectiveness Research and Education

Dr. Bhatia's current focus is to establish a comprehensive program for cancer outcomes and survivorship research at UAB. This program will reduce the burden of cancer and its sequelae across all segments of the population through collaborative interdisciplinary, interventional and educational efforts in Pediatrics and other Departments.  She also serves as the Associate Chair for the Chidren’s Oncology Group (COG), coordinating survivorship research across 200 pediatric oncology institutions in the U.S.  Dr. Bhatia is an elected member in the American Society for Clinical Investigation.

Christy Bemrich-Stolz, M.D.ChristyB-Ssmall

Dr. Bemrich-Stolz is an Instructor in the UAB Division of Pediatric Hematology-Oncology.  She is a graduate of the University the University of Alabama School of Medicine.  She completed pediatric residency training at Children’s of Alabama followed by her fellowship training in pediatric hematology-oncology.  While completing her fellowship, she received her MSPH in Outcomes and Effectiveness research at the UAB School of Public Health.  Dr. Bemrich-Stolz’s clinical practice includes general hematology and oncology though she does have a particular interest in caring for patients with sickle cell anemia.  Her research interests include assessment of quality of life, transition to adult care and cost-effectiveness of treatment for patients with sickle cell disease.


Chewning_postJoseph Chewning, M.D.
Associate Professor of Pediatrics
Blood and Marrow Transplantation Program

Dr. Chewning is a graduate of Davidson College and the University of South Carolina Medical School. After completing a pediatric residency and a chief residency year at Erlanger Hospital in Chattanooga, he trained in pediatric hematology-oncology at Memorial Sloan-Kettering Cancer Center.  Dr. Chewning remained at Memorial Sloan-Kettering where he did an additional fellowship in bone marrow transplantation while performing human Natural Killer Cell research.  Currently, Dr. Chewning's research focus is translational studies for the prevention and treatment of graft versus host disease.  Dr. Chewning is developing novel mouse models exploring the role of CD4+ T cell lineages in mediating graft versus host disease.  Dr. Chewning is also designing clinical research protocols for mechanisms of chronic graft versus host disease in pediatric patients undergoing hematopoietic stem cell transplantation.


Stuart Cramer, D.O.
Assistant ProfessorSCramer

Dr. Cramer is a graduate of the University of Florida and attended Nova Southeastern College of Osteopathic Medicine in Ft. Lauderdale Florida for medical school.  After medical school, he went on to complete his pediatric residency at the University of South Carolina and his Pediatric Hematology and Oncology fellowship at UAB.  Dr. Cramer is interested in cancer cell biology, specifically chemotherapeutic drug resistance.  He is currently working in collaboration with Dr. Mary-Ann Bjornsti, chair of the Department of Pharmacology and Toxicology, investigating the experimental drug MLN 8237 an Aurora A kinase inhibitor in neuroblastoma.  As a fellow, Dr. Cramer received research funding from the St. Baldrick’s Foundation allowing him to explore the role drug transporters play in neuroblastoma drug resistance, and has been granted an extra year of funding by the foundation.  Dr. Cramer hopes that a better understanding of cancer cell resistance will improve outcomes in hard to treat pediatric cancers.


FriedmanGregory Friedman, M.D.  
Associate Professor of Pediatrics   
Neuro-Oncology Program

Dr Friedman is a graduate of the College of William and Mary and the Medical College of Georgia.  He completed his pediatric residency and fellowship in pediatric hematology/oncology at UAB, and is board certified in pediatrics and pediatric hematology/oncology.  His primary interests are pediatric neuro-oncology and conducting pediatric brain tumor research. His overarching goal is to improve outcomes for children with malignant brain tumors by developing and improving novel, targeted therapeutics like oncolytic engineered herpes simplex virotherapy (oHSV) in the lab and then translating these therapies to clinical trials to benefit children with brain tumors and other solid tumors. To maximize the benefit of oHSV to treat chemo- and radio-resistant brain tumors, his lab focuses on determining mechanisms of therapeutic resistance to oHSV by exploring the role of tumor genotype, phenotype, the tumor microenvironment, and cellular defense mechanisms so that newer viruses and unique routes of virus delivery may be developed to circumvent resistance mechanisms. 

Goldman_postFrederick Goldman, M.D.
Professor of Pediatrics
Director, Lowder Pediatric Blood and Marrow Transplantation Program
Senior Scientist Immunology & Cancer  
     Immunotherapeutics Program
UAB Comprehensive Cancer Center

Dr. Goldman is a Professor of Pediatrics and Director of the Lowder Blood and Marrow Transplant Program and a member of the Division of Pediatric Hematology-Oncology. Dr. Goldman is a graduate of the Louisiana State University School of Medicine. He completed pediatric residency training at Tulane Children's Hospital and fellowship training at Denver Children's Hospital.  He did a post-doctoral fellowship in Immunology at National Jewish Center for Immunology.  He is a recent UAB faculty member, joining the program in June, 2009, after being on faculty at the University of Iowa since 1992, where he was the Director of the Pediatric Bone Marrow Transplant program and the Pediatric Immune Disorders program.   He is board certified in Pediatric Hematology Oncology. Dr. Goldman's basic science research focuses on understanding the role of a specific enzyme complex called telomerase in cancer, bone marrow production, and aging, and how this enzyme is crucial in minimizing toxicities of chemotherapy.  In addition, Dr. Goldman is involved in studies of new gene transfer methods to treat marrow failure syndromes (Dyskeratosis congenita) and disorders of hematopoiesis (sickle cell disease).  His clinical interests center on developing protocols utilizing cord blood transplant as a way to treat a wide array of childhood cancers, including ALL and AML, as well as inherited immune deficiencies and marrow failure disorders.  He is also directing clinical studies to asses the role of immunoglobulin to prevent infections in pediatric oncology patients. Dr. Goldman has been recognized for clinical excellence by selection as one of the "Best Doctors in America" from 2006 to the present.

HainesHilary Haines, M.D. 
Assistant Professor of Pediatrics
Division of Hematology and Oncology


Dr. Haines obtained her undergraduate degree from Louisiana State University, and is a graduate of Louisiana State University School of Medicine in New Orleans.  She completed her pediatric residency and pediatric hematology/oncology fellowship here at UAB.  Following completion of her hematology/oncology fellowship, she completed an additional fellowship in bone marrow transplantation and immunodeficiency at Cincinnati Children's Hospital.  She is board certified in pediatrics and pediatric hematology/oncology.  Dr. Haines' clinical interests include supportive care and treatment of viral infections in bone marrow transplant patients and bone marrow transplant for non-malignant disease such as immunodeficiency and sickle cell disease.

HilliardLee M. Hilliard, M.D.
Professor of Pediatrics
Chair, CHS Blood Utilization Committee

Dr. Hilliard's area of focus is hematology.  Specifically, her interests include clinical care and research in sickle cell disease.  Dr. Hilliard focuses on stroke risk assessment and prevention, health care delivery in rural areas, management of iron overload in chronically transfused patients (including the use of erythrocytapheresis) and the use of hydroxyurea in sickle cell disease.

Thomas H. Howard, M.D.
Professor of Pediatrics
Director, Hematology Section
Co-Director UAB Comprehensive Sickle Cell Center

Dr. Howard hails from North Carolina, graduated from the University of North Carolina at Chapel Hill in
Chemistry, and received his MD degree from the Johns Hopkins University School of Medicine (JHUSOM).  After completing pediatric residency at The Johns Hopkins Hospital in Baltimore MD, he pursued a pediatric hematology and oncology fellowship with William Zinkham MD in the JHUSOM, Department of Pediatrics.  He is board certified in pediatrics and pediatric hematology and oncology.  He served on the faculty in the schools of medicine at JHU, The University of Virginia (UVA) and at the University of Alabama Birmingham (UAB) since 1985.  He was a Visiting Professor of Medicine at Harvard University in 1993-1994 .  During his career he has served as a member of NIH Hematology Grant Study Sections, as commissioner on state commissions for sickle cell disease and hemophilia, as director of the UAB pediatric hematology section and of pediatrics hematology and oncology divisions. 

Dr. Howard's primary clinical interest is general hematology with a focus on sickle cell disease (SCD), hemophilia and red and white blood cell defects.  Dr. Howard's research career interests and experience include an NIH funded basic research program focused on assembly and regulation of the molecular motor in neutrophils; his clinical research focuses on neurological abnormalities, health care delivery, and novel therapies for SCD.  Currently he is institutional PI for NHLBI studies (The Baby Hydroxyurea Trial, Co-PI on the JHU/UAB Basic and Translational Research Program, The JHU Priapism Project), NINDS grants (The Silent Infarct Transfusion Trial, Hydroxyurea for Silent Infarcts in Sickle Hemoglobinopathies), and HRSA projects (Sickle Cell Treatment Demonstration Project) and industry sponsored trials of a novel pneumococcal vaccine.  He, in collaboration with Lee Hilliard MD, founded and developed the Children and Youth Sickle Network (The CYSNTM), a network of regional, comprehensive SCD clinics focused on prevention of SCD morbidity and mortality. The network, established in 1994, collaborates with local pediatricians, SCDAA chapters, hospital and clinics, is an unique, nationally recognized care system and has served Alabamians continuously since its inception. 


KutnyMatthew Kutny, M.D.
Assistant Professor of Pediatrics

Dr. Kutny is a graduate of Brown University and Vanderbilt University School of Medicine. He completed training in pediatrics at Vanderbilt University Children’s Hospital. He then trained in Pediatric Hematology/Oncology and Bone Marrow Transplant through the University of Washington at the Fred Hutchinson Cancer Research Center and Seattle Children’s Hospital. Dr. Kutny’s clinical practice includes both general hematology and oncology and bone marrow transplant. His research interests focus on the treatment of pediatric leukemia. He is working to improve risk stratification and treatment allocation for patients with acute myeloid leukemia and developing new targeted treatments for relapsed and de novo leukemia.

Wendy Landier, PhD, R.N.Wendy Landier announcement 2 01
Associate Professor
Dr. Landier is a leader with Dr. Bhatia in defining the key issues of the late effects of childhood cancer therapy. Her research focuses on understanding and improving health outcomes in cancer survivors. She is a Pediatric Nurse Practitioner and also holds a PhD in Nursing. She Chairs the Nursing Discipline Committee for the Children’s Oncology Group. She is extensively published with approximately 50 peer-reviewed manuscripts and multiple book chapters. She is well funded as an individual and as an active colleague in Dr. Bhatia’s research program. Dr. Landier holds a dual appointment in the School of Nursing where she serves as an important mentor for nursing students.

Lebensburger_postJeffrey Lebensburger, D.O.
Assistant Professor of Pediatrics

Dr. Lebensburger is a graduate of the University of Pennsylvania for undergraduate training and the Nova Southeastern Medical School. After his pediatric residency at Arnold Palmer Hospital for Children in Orlando, Florida, Dr. Lebensburger completed fellowship training in Pediatric Hematology Oncology at St. Jude Children's Research Hospital. His primary focus involves children with disorders of the blood, especially sickle cell Disease, thalassemia, disorders of iron metabolism, and marrow failure syndromes including aplastic anemia. His research focuses on linking knowledge from basic science to clinical care (translational research) especially in sickle cell disease. A long term goal of the research is gene therapy for blood disorders.

Purmina Singh, PhDPHO-00785 Dr. Purnima Singh 001mod
Assistant Professor

Dr. Singh is a collaborator with Dr. Bhatia's cancer outcomes team and is an integral part of the new SOM Institute for Cancer Outcomes and Survivorship.

Madan-Swain_postAvi Madan-Swain, PhD
Associate Professor of Pediatrics
Director, Hope and Cope Psychosocial Program

Dr. Madan-Swain is a Pediatric Psychologist/Neuropsychologist and Clinical Associate Professor in the Division of Pediatric Hematology/Oncology and Neurology, University of Alabama at Birmingham.   She received her doctorate in clinical psychology from Georgia State in 1998, as well as a doctorate in Special Education from Purdue University in 1984. She completed internship training at the UAB Department of Neuropsychiatry and post-doctoral fellowships in Pediatric Psychology and Neuropsychology at Children's of Alabama and the UAB Department of Pediatrics.  Dr. Madan-Swain has worked extensively with chronically ill children and their families in both inpatient and outpatient settings. She is actively engaged in research focusing on school reentry for chronically ill youth, as well as individual and familial adaptation and coping, quality of life issues and neurocognitive functioning in survivors of childhood leukemia, brain tumors, and blood and marrow transplants.

 Reddy_postAlyssa Reddy, M.D.
Professor of Pediatrics
Director, Neuro-Oncology Program

Dr. Reddy is a Professor of Pediatrics, Neurology, and Surgery at UAB.  Dr. Reddy received her undergraduate degrees from Boston University and medical degree from UAB.  She completed residency training in Pediatrics at UAB, fellowship training in Child Neurology at UAB, and training in Pediatric Neuro-Oncology at Children's National Medical Center in DC.  Dr. Reddy was instrumental in starting the UAB Pediatric Neuro-Oncology Clinic in 1998, which today is one of the largest programs of its kind in the US.  Dr. Reddy's research interests include development and implementation of clinical trials for children with nervous system tumors.  She is currently principal investigator (PI) of the international Children's Oncology Group (COG) Atypical Teratoid Rhabdoid trial and serves on the Infant Brain Tumor and Neurology Subcommittees of COG.  Dr. Reddy is also the UAB Institution principal investigator for COG as well as several multi-center treatment and cognitive effects studies.  She is also a Co-Investigator for the UAB Neurofibromatosis Consortium.  Dr. Reddy's goal is to improve the lives of children with brain and spinal cord tumors through outstanding patient care and research. 

Whelan_KimberlyKimberly Whelan, M.D., MSPH
Associate Professor of Pediatrics
Director, TLC clinic and Childhood Cancer Survivors Program
Director, Hem/ Onc Fellowship Program

Dr. Whelan is a graduate of the University of South Carolina's School of Medicine. She completed her pediatric residency at Vanderbilt University Medical Center and later her fellowship in pediatric hematology and oncology here at UAB. She is currently the Medical Director of the TLC clinic. The focus of her research is the late effects of cancer therapy.

Ana Xavier, M.D.
Assistant Professor